Trexquant Investment’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-257,716
Closed -$1.89M 1611
2024
Q1
$1.89M Buy
+257,716
New +$1.6M 0.04% 678
2023
Q3
Sell
-333,986
Closed -$1.59M 1564
2023
Q2
$1.59M Sell
333,986
-31,400
-9% -$173K 0.04% 583
2023
Q1
$2.08M Buy
365,386
+173,449
+90% +$1.05M 0.06% 445
2022
Q4
$1.94M Buy
191,937
+129,049
+205% +$2.42M 0.05% 418
2022
Q3
$1.41M Buy
62,888
+54,168
+621% +$1.57M 0.05% 436
2022
Q2
$216K Buy
+8,720
New +$241K 0.01% 1313
2021
Q4
Sell
-15,428
Closed -$914K 1395
2021
Q3
$914K Buy
+15,428
New +$1.21M 0.07% 345
2021
Q2
Sell
-13,516
Closed -$1.11M 1212
2021
Q1
$1.11M Buy
13,516
+2,461
+22% +$236K 0.1% 251
2020
Q4
$1M Buy
+11,055
New +$687K 0.11% 256
2020
Q1
Sell
-33,373
Closed -$653K 1208
2019
Q4
$653K Buy
+33,373
New +$530K 0.04% 484
2018
Q2
Sell
-18,369
Closed -$179K 980
2018
Q1
$179K Buy
+18,369
New +$176K 0.01% 963

Other funds holding FATE